Labs / Assays & in vitro testing
Nuvisan
Neu-Ulm, Germany · nuvisan.com
GMP
Nuvisan is a CRO/CDMO that supports drug discovery, preclinical, clinical, and CMC development for pharmaceutical and biotechnology clients, as well as research institutions and the veterinary industry. It operates from locations in Germany and France, and also connects chemistry services with a synthesis lab in Hyderabad, India. It works across small and large molecules and multiple therapeutic modalities.
They take quote requests by email.
What they offer
Discovery services
Supports target understanding, target identification and validation, omics and biomarkers, biosciences, compound screening, pharmacology, chemistry, and discovery DMPK.
Preclinical development
Supports preclinical candidate development with DMPK and preclinical safety services.
Clinical services phase 1 & 2
Provides phase 1–2 clinical trial support including clinical pharmacology unit studies, multicentre patient studies, clinical operations, data management, biostatistics, drug safety, consulting, and clinical laboratory services.
Clinical trial supply services
Provides investigational medicinal product manufacturing, packaging and labelling, logistics, storage, distribution, return and destruction, comparator sourcing, direct-to-patient shipments, compassionate use, expanded access, and controlled drug handling.
Pharmaceutical analytical services
Provides analytical support for small and large molecules, including method development and validation, quality control, stability studies, EU re-testing, and commercial release.
Drug substances
Supports drug substance development and related CMC work within integrated solutions.
Drug products
Supports drug product development and related CMC work within integrated solutions.
Bioanalysis
Provides bioanalytical support in preclinical and clinical development.
Biomarkers
Provides biomarker services within discovery and clinical workflows.
Digital science technologies
Provides an integrated digital platform including electronic lab notebook, LIMS, compound registration, assay data management, and reporting tools.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Peptide, Gene editing, Vaccine, Biosimilar
- Species and models
- tumour-bearing animal models, in vivo models
- Assays and studies
- high-throughput screening, fragment screening, virtual screening, biophysical analyses, structure-based design, CRISPR/Cas9, RNA interference, single-cell sequencing, bioanalysis, method development, method validation, quality control, and 3 more
- Instruments and platforms
- electronic lab notebook, LIMS
- Scale and capacity
- more than 5.000 m² GMP facilities, more than 320 m² of stability storage, six full-time qualified persons
- Therapeutic areas
- oncology, dermatology
- What to send
- sample barcoding
- Type
- CRDMO
- Sites
- Neu-Ulm, Germany · Berlin, Germany · Sophia Antipolis, France · Grafing, Germany · Waltrop, Germany · Hyderabad, India
- Team
- more than 100 analytical experts across Europe
- Quality
- GMP (laboratories, manufacturing, packaging, release, and clinical trial supply activities) · GLP (laboratories) · ICH/VICH guidelines (QC testing) · EU-GDPR (digital platform) · NIST standards (digital platform) · EU GMP (market authorisation case study) · GCP (early clinical trials) · GDP (clinical trial supply)
- Serves
- Europe, worldwide
- Address
- Wegenerstrasse 13 89231 Neu-Ulm Germany Berlin Muellerstrasse 178 13353 Berli
Public records
Similar labs. Pacific BioLabs, HitGen, Laxai Life Science, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from nuvisan.com. Work here? Claim this listing.